Chendhore Veerappan
Research Analyst at Diamond Hill Capital Management Inc.
About
Chendhore Veerappan, PhD, CFA, is an International Research Analyst at Diamond Hill Capital Management, Inc., based in Carlsbad, California. He joined Diamond Hill in 2015 and currently conducts in-depth fundamental research for the firm's investment strategies, with a primary focus on the global healthcare sector, including biotechnology and emerging market healthcare opportunities.
Dr. Veerappan brings over a decade of investment experience, leveraging his advanced scientific training—he holds a bachelor's degree in computer science, a master's in bioinformatics, a PhD in genetics and molecular biology, and an MBA. Prior to his investment career, he was involved in academic research and grant writing, experiences that inform his analytical approach to investing in innovative and complex health sciences markets.
At Diamond Hill, Dr. Veerappan is recognized for identifying high-quality, attractively valued companies, particularly within healthcare and biotechnology, across both developed and emerging markets. His contributions include thought leadership on sector trends such as global drug pricing and biotechnology rebound cycles, and he plays a key role within Diamond Hill’s international equity team, helping shape the firm’s selective, risk-conscious investment approach.
Career History
| Organization | Role | Date Range | Details |
|---|---|---|---|
| Diamond Hill Capital Management, Inc. | Research Analyst | Jan 2021 to Present | — |
| Keck Graduate Institute | Faculty | Mar 2023 to May 2023 | Adjunct faculty. Valuation in the Life Sciences |
| Pfizer | Project Consultant | Jan 2014 to Dec 2014 | Constructed user controlled orphan drug designation database for Pfizer. Part of a two semester capstone project at Keck Graduate Institute |
| Regeneron Pharmaceuticals, Inc. | Corporate Residency Program | Jun 2014 to Aug 2014 | Clinical Development and Regulatory Affairs intern - Part of the Immunology/Inflammation and Muscle Disorder therapeutic focus area teams - Authored 4 orphan drug designation application drafts Sectio... |
| UCLA David Geffen School of Medicine | Postdoctoral Scholar | Jan 2013 to Dec 2013 | • Genetic and epigenetic analysis of disease risk using next generation high-throughput datasets derived from patients with neurodegenerative disorders. • Invited to author a review article about the ... |
| Keck Graduate Institute | Bioscience Management Bootcamp | Jul 2013 to Jul 2013 | Bioscience business strategy. Decision, value chain and market analysis. Intellectual property strategy. Basics of accounting, corporate finance and valuation. |
| University of Southern California | Research Assistant (Ph.D.) | Aug 2007 to Dec 2012 | • Extensive experience in Molecular Biology, Computer Science, Epigenetics and Next Generation Sequencing (NGS) • Research conducted in the fields of epigenetics and human embryonic stem cells • Three... |
| University of Nebraska-Lincoln | Masters and Undergraduate Teaching and Research Assistant | Feb 2002 to Aug 2007 | • Performed sequence similarity searches, gene architecture analysis and applied various phylogenetic reconstruction and alignment algorithms • Peer-reviewed first author publication • Over three year... |
| Microsoft | National Senior Design Competition | Aug 2003 to May 2004 | • Successfully completed the design, engineering and implementation of 'Acoustic Scan', a public gunshot detection and response system within cost, hardware and time parameters • Experienced working i... |
| Diamond Hill Capital Management, Inc. | Research Associate | Feb 2015 to Jan 2021 | Pharmaceuticals, Biotech, and International Healthcare |
| UCLA Advanced Degree Consulting Club | Board Member | Mar 2013 to Nov 2013 | • Involved in coordinating and hosting club events and outreach to industry with a goal to promote careers in management consulting. • Administration of day-to-day operations and maintenance of offici... |
| Keck Graduate Institute | Jul 2013 to Jul 2013 | Bioscience business strategy.<br>Decision, value chain and market analysis.<br>Intellectual property strategy.<br>Basics of accounting, corporate finance and valuation. |
Education
Keck Graduate Institute
Postdoc Professional Masters, Bioscience Management
2014 — 2014
University of Southern California
Doctor of Philosophy (Ph.D.), Genetics, Molecular and Cellular Biology
2007 — 2012
University of Nebraska-Lincoln
Masters, Biology
2005 — 2007
University of Nebraska-Lincoln
Bachelors, Computer Science
2001 — 2004
Others at Diamond Hill Capital Management Inc. (23)
| Name | Role | Location |
|---|---|---|
 | Portfolio Manager | United States |
 | Analyst | New York, NY , United States |
A Arthur Cheng | Portfolio Manager | Los Angeles, CA , United States |
 | Research Analyst | Columbus, OH , United States |
D Dana Wainer | Accounting and Business Analyst | Columbus, OH , United States |
 | Managing Director - Information Technology | Columbus, OH , United States |
K Krishna Mohanraj | Portfolio Manager | Groveport, OH , United States |
K Kristen Christman | Senior Product Analyst | Columbus, OH , United States |
 | Portfolio Manager | Columbus, OH , United States |
P Patrick Trencansky | Senior Performance Analyst | Jacksonville, FL , United States |